Associate Director GD Change & Engagement
Regeneron Pharmaceuticals
Summary
The Associate Director, GD Engagement leads the design and delivery of change communications and engagement strategies across GD transformation initiatives. This is a player-coach role responsible for both setting direction and executing high-quality work. The role partners closely with Change Management to ensure that change is clearly communicated, effectively experienced, and successfully adopted across leaders, managers, and teams.
Job description
Build our future together
The Associate Director, GD Engagement leads the design and delivery of change communications and engagement strategies across GD transformation initiatives. This is a player-coach role responsible for both setting direction and executing high-quality work. The role partners closely with Change Management to ensure that change is clearly communicated, effectively experienced, and successfully adopted across leaders, managers, and teams.
This role will focus on building and establishing a scalable engagement capability, demonstrating value through delivery on priority programs while creating the foundation for a more strategic, enterprise-level function over time.
Lead & Deliver Change Communications
- Partner with Change on priority transformation initiatives to develop and execute end-to-end comms and engagement strategies
- Translate change impacts into clear messages, narratives, and audience-driven communication plans
- Lead development of critical deliverables (content, campaigns, engagement plans)
- Ensure communications reinforce change intent, behaviors, and outcomes
Operate as a Player-Coach
- Provide hands-on support and coaching to change leads and partners on comm and engagement approaches
- Step into execution where needed, particularly on complex or high-visibility initiatives
- Model what good looks like through delivery—not just guidance
Build & Scale Engagement Capability
- Develop templates, playbooks, and communication frameworks to enable scalable support across GD
- Establish standards, governance guardrails, and ways of working aligned to transformation priorities
- Enable self-service through tools and guidance, reducing reliance on centralized execution
- Design and deliver leader and manager communication enablement (toolkits, cascades, messaging support)
- Gather feedback on readiness and engagement, adjusting approaches accordingly
Drive High-Quality Execution
- Lead execution of communications across channels (email, intranet, campaigns, newsletters, etc.)
- Develop clear, compelling written and visual content in partnership with design resources
- Ensure consistency in voice, tone, and messaging across initiatives
- Track effectiveness and continuously improve engagement outcomes
Lead Integrated Creative Team
- Partner with editorial, visual design and UX resources to deliver compelling, outcome-focused storytelling
- Shape messaging and narrative upstream of execution, ensuring alignment between strategy and design
- Manage external resources to deliver scaled, high-quality outputs
Partner Across GD Communications Ecosystem
- Collaborate with Corp Comms to ensure alignment between enterprise messaging and transformation comms
- Partner with program teams and senior leaders on executive-level communications and engagement moments
Requirements
- Minimum of a Bachelor's Degree
- 10+ years relevant work experience
- Prosci or ACMP certifications are a plus but not required
- Prior work experience in biotech/pharma/healthcare is helpful
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Medical, Dental & Vision
- Life and disability insurance
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.